Oxidative Stress Does Not Influence Subjective Pain Sensation in Inflammatory Bowel Disease Patients.

Crohn’s disease inflammatory bowel diseases oxidative stress pain ulcerative colitis

Journal

Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981

Informations de publication

Date de publication:
01 Aug 2021
Historique:
received: 10 06 2021
revised: 23 07 2021
accepted: 29 07 2021
entrez: 27 8 2021
pubmed: 28 8 2021
medline: 28 8 2021
Statut: epublish

Résumé

Oxidative stress (OS) has been proposed as a significant causative and propagating factor in inflammatory bowel diseases (IBDs). Modulation of OS is possible through antioxidants and inhibition of oxidizing enzymes. Thirty-one IBD patients and thirty-two controls were included in the study. The aim was to examine the levels of OS in colonic tissue of IBD requiring surgical intervention and control group, and their association with pain intensity. Total antioxidant capacity (TAC), superoxide dismutase (SOD) and catalase (CAT) activity, glutathione (GSH) and oxidized glutathione (GSSG) levels, and glutathione peroxidase (GPX) activity as markers of antioxidant defense were determined. Cyclooxygenases activities (Total COX, COX-1 and COX-2) were measured as prooxidant enzymes. Thiobarbituric acid reactive substances (TBARS) concentrations were measured to evaluate lipid peroxidation. Disease activity was assessed, and each subject filled out VAS and Laitinen's pain assessment scales. Correlation between the OS, pain intensity, disease activity parameters, C-reactive protein (CRP), number of stools passed daily, disease duration, and dietary habits was investigated. No TAC differences were found between the groups. A significant decrease of SOD activity and GSH and GSSG levels was seen in IBD patients vs. controls, while GPX activity was diminished significantly only in CD patients. CAT and COX-1 activity was increased, and COX-2 significantly decreased in IBD. TBARS were significantly higher in CD patients compared to control group. No correlation was found between pain scores, inflammatory status, disease activity, disease duration, or dietary habits and OS markers. In our study, OS did not influence pain sensation reported by IBD patients.

Identifiants

pubmed: 34439485
pii: antiox10081237
doi: 10.3390/antiox10081237
pmc: PMC8389030
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Uniwersytet Medyczny w Lodzi
ID : 503/1-156-04/503-11-001-19-00 to JF

Références

J Crohns Colitis. 2016 Nov;10(11):1316-1323
pubmed: 27095753
Redox Biol. 2015 Dec;6:617-639
pubmed: 26520808
Dis Colon Rectum. 1999 Jan;42(1):71-6
pubmed: 10211523
J Med Biochem. 2017 Oct 28;36(4):341-348
pubmed: 30581331
Inflamm Bowel Dis. 2020 Jan 1;26(1):114-124
pubmed: 31127829
Dig Dis Sci. 2004 Nov-Dec;49(11-12):1752-7
pubmed: 15628697
Pol Przegl Chir. 2020 May 26;92(5):8-15
pubmed: 33028732
Gut. 1998 Apr;42(4):485-92
pubmed: 9616308
Inflamm Bowel Dis. 2010 Sep;16(9):1467-75
pubmed: 20186929
Cranio. 2004 Jul;22(3):250-6
pubmed: 15293781
Oxid Med Cell Longev. 2017;2017:4535194
pubmed: 28744337
Ann N Y Acad Sci. 2006 Dec;1091:110-22
pubmed: 17341608
J Physiol Pharmacol. 2016 Oct;67(5):709-715
pubmed: 28011951
Redox Rep. 2015 Jul;20(4):163-9
pubmed: 25551736
Pol Arch Intern Med. 2018 Jun 30;128(6):362-370
pubmed: 29806822
Int J Colorectal Dis. 2019 Feb;34(2):217-227
pubmed: 30564910
Inflammation. 2020 Aug;43(4):1411-1422
pubmed: 32240451
J Basic Clin Physiol Pharmacol. 2014 Feb;25(1):59-62
pubmed: 23839812
J Crohns Colitis. 2013 Oct;7(9):e358-66
pubmed: 23523266
Clin Chem Lab Med. 2012 Mar 03;50(8):1359-66
pubmed: 22868800
Am J Physiol Gastrointest Liver Physiol. 2011 Jan;300(1):G41-51
pubmed: 20947704
Antioxidants (Basel). 2019 Sep 06;8(9):
pubmed: 31489956
Int J Mol Sci. 2020 Nov 13;21(22):
pubmed: 33202858
Saudi J Gastroenterol. 2013 May-Jun;19(3):131-5
pubmed: 23680711
Diagnostics (Basel). 2020 Aug 17;10(8):
pubmed: 32824619
Expert Opin Drug Discov. 2020 Nov;15(11):1309-1341
pubmed: 32749894
Inflamm Bowel Dis. 2012 Dec;18(12):2342-56
pubmed: 22467146
Gut. 2019 Dec;68(Suppl 3):s1-s106
pubmed: 31562236
Nutrients. 2019 Dec 20;12(1):
pubmed: 31877637
World J Gastroenterol. 2011 May 21;17(19):2417-23
pubmed: 21633642
Oxid Med Cell Longev. 2018 Jul 2;2018:7918261
pubmed: 30057685
Biochem Med Metab Biol. 1994 Dec;53(2):87-91
pubmed: 7710773
Complement Ther Med. 2019 Apr;43:1-6
pubmed: 30935515
Dig Dis Sci. 2013 May;58(5):1244-9
pubmed: 23306840
Dig Liver Dis. 2002 Oct;34(10):696-701
pubmed: 12469796
J Pathol. 2003 Sep;201(1):28-36
pubmed: 12950014
Gastrointest Endosc Clin N Am. 2014 Jul;24(3):367-78
pubmed: 24975528
Antioxidants (Basel). 2021 Jan 07;10(1):
pubmed: 33430227
Indian J Med Res. 2014 Apr;139(4):568-71
pubmed: 24927343

Auteurs

Anna Krystyna Zielińska (AK)

Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.

Maciej Sałaga (M)

Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.

Paweł Siwiński (P)

Department of General and Colorectal Surgery, Faculty of Medicine, Medical University of Lodz, Żeromskiego 113, 90-549 Lodz, Poland.

Marcin Włodarczyk (M)

Department of General and Colorectal Surgery, Faculty of Medicine, Medical University of Lodz, Żeromskiego 113, 90-549 Lodz, Poland.

Adam Dziki (A)

Department of General and Colorectal Surgery, Faculty of Medicine, Medical University of Lodz, Żeromskiego 113, 90-549 Lodz, Poland.

Jakub Fichna (J)

Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.

Classifications MeSH